Lifevantage (NASDAQ:LFVN) Stock Passes Above 200 Day Moving Average – Here’s What Happened

Lifevantage Corporation (NASDAQ:LFVN) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $5.73 and traded as high as $10.50. Lifevantage shares last traded at $9.49, with a volume of 710,001 shares traded.

Analysts Set New Price Targets

Several analysts have commented on the stock. Lake Street Capital lowered shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target for the company. in a research report on Thursday, May 7th. Weiss Ratings raised shares of Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $5.00.

Lifevantage Trading Down 4.6%

The business’s 50-day moving average price is $6.02 and its 200-day moving average price is $5.76. The stock has a market cap of $114.17 million, a PE ratio of 20.11 and a beta of 0.69.

Lifevantage (NASDAQ:LFVN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). Lifevantage had a return on equity of 23.89% and a net margin of 2.94%.The firm had revenue of $43.72 million during the quarter, compared to analysts’ expectations of $47.77 million. As a group, analysts predict that Lifevantage Corporation will post 0.6 earnings per share for the current year.

Lifevantage Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 2.2%. This is a boost from Lifevantage’s previous quarterly dividend of $0.05. The ex-dividend date is Monday, June 1st. Lifevantage’s dividend payout ratio (DPR) is 44.44%.

Institutional Investors Weigh In On Lifevantage

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LFVN. DGS Capital Management LLC purchased a new stake in Lifevantage in the first quarter valued at about $44,000. Hsbc Holdings PLC purchased a new stake in Lifevantage in the first quarter valued at about $51,000. JPMorgan Chase & Co. raised its stake in Lifevantage by 870.2% in the second quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock valued at $66,000 after buying an additional 4,499 shares during the last quarter. Franklin Resources Inc. purchased a new stake in Lifevantage in the fourth quarter valued at about $74,000. Finally, Aristides Capital LLC purchased a new stake in Lifevantage in the fourth quarter valued at about $76,000. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.